Apply on Employer Site

Ionis Pharmaceuticals, Inc. · 7 hours ago

2026 Summer Intern | Business Development

Carlsbad, CA

Internship

Hybrid

Intern

$18/hr - $23/hr

Start in 2026 Summer

Ionis Pharmaceuticals, Inc. is a pioneering company in RNA-targeted medicines, aiming to revolutionize drug discovery. The Business Development Intern will support the team by generating ideas for partnerships and improving transaction processes, contributing to the company's strategic goals.

BiotechnologyHealth CareMedicalPharmaceutical

Responsibilities

Conduct market research across a range of topics, which may include the current standard of care for diseases, identification of potential therapeutic ideas for diseases enabled by emerging platform technologies, clinical-stage asset landscapes, or analyses of public contracts

Design systems to improve the BD/AM transaction processes, which may include knowledge repositories, reference documents, executive presentation templates, transaction post-mortems, or workflow tools

Monitor market and industry trends

Review prior deals, transaction terms, and contracts to identify patterns, benchmarks, and potential best practices that can inform BD negotiations

Synthesize findings into summaries, presentations, or frameworks

Qualification

Market researchAnalytical skillsBusiness developmentTransaction process improvementIntellectual curiosityLogical thinkingResourcefulnessClear communication

Required

MUST be currently enrolled in a U.S. Undergraduate and/or Graduate Degree Program and not graduating prior to the completion of the Ionis internship

MUST be able to begin internship between 6/8 and 8/14/2026

MUST be able and willing to remain in program through at least 8/14/2026

MUST be able and willing to commit to a minimum 40-hour work week

Benefits

Weekly stipend (for onsite interns only)

Housing/Travel assistance available for eligible, out-of-area interns

Professional Networking

Networking and bonding social events

Interaction with diverse and motivated teams/departments

Company

Ionis Pharmaceuticals, Inc.

Glassdoor4.0

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases.

Founded in 1989

Carlsbad, California, USA

501-1000 employees

http://www.ionispharma.com

Funding

Current Stage

Public Company

Total Funding

$2.45B

2025-11-13Post Ipo Debt· $700M

2024-09-09Post Ipo Equity· $500.3M

2023-06-06Post Ipo Debt· $500M

Leadership Team

Brett P. Monia

Chief Executive Officer

Eric Bastings

Senior Vice President, Development Strategy

Recent News

Labiotech UG

Hepatitis B: Are we edging closer to a cure?

2026-01-22

Business Wire

DAWNZERA™ (donidalorsen) approved in the European Union for hereditary angioedema (HAE)

2026-01-22

PharmiWeb

Dawnzera™ (donidalorsen) granted European Union marketing authorisation for the prevention of hereditary angioedema

2026-01-22

Company data provided by crunchbase